Gland Pharma Limited Overview
Pro stress-test →Gland Pharma manufactures and sells injectable formulations globally while developing pharmaceutical active pharmaceutical ingredients including complex molecules like low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. Established in Hyderabad in 1978, the company has grown from a contract manufacturer to become one of the largest and fastest-growing injectable-focused companies with global presence across 60 countries.
Strategic Profile
Pro stress-test →Operating under a business-to-business model, the company has demonstrated excellence in developing, manufacturing and marketing complex injectables with presence across the value chain enabling exponential growth. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Competitive Landscape
Pro stress-test →Gland Pharma is covered by 26 analysts with 12 providing revenue/earnings estimates. The company operates in India's injectable pharmaceuticals space competing against diversified pharma majors. The company maintains global presence in 60 countries operating on a B2B model in India, USA, Canada, Australia, and European countries.
Industry Context
Gland Pharma Limited operates in Pharmaceutical Manufacturing - Injectable Formulations & APIs.
Key facts
Founded: 1978 · Headquarters: Hyderabad, India · Revenue: ₹5,830.11 Cr (FY2025-26) · Market cap: ₹31,065 Cr